Evidence map›Paper›PMID 30007046›Full record

ArticleThe Journal of comparative neurology2018

Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian rats.

Tiago Cardoso, Andrew F Adler, Bengt Mattsson, Deirdre B Hoban, Sara Nolbrant, Jenny Nelander Wahlestedt, Agnete Kirkeby, Shane Grealish, Anders Björklund, Malin Parmar

Registry-linked trialAbstract read
In one paragraph

Article in The Journal of comparative neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05635409 (STEM-PD Trial), which is not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05635409 phase1active not recruitingnot on this mapstarted 2022, after this paper: background citation

STEM-PD Trial: A Multicentre, Single Arm, First in Human, Dose-escalation Trial, Investigating the Safety and Tolerability of Intraputamenal Transplantation of Human Embryonic Stem Cell Derived Dopaminergic Cells for Parkinson's Disease (STEM-PD Product)

TypeinterventionalSponsorRegion SkaneRan2022 to 2027Enrolled8ConditionsParkinson DiseaseArmsSTEM-PD
3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Wrap it up: myelination of transplanted neurons for repair.Frontiers in cellular neuroscience · 2025
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. iPSCs-Derived Neurons and Brain Organoids from Patients.Handbook of experimental pharmacology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tiago CardosoDevelopmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.ORCID 0000-0003-2686-458X
Andrew F AdlerDevelopmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Bengt MattssonDevelopmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Deirdre B HobanDevelopmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Sara NolbrantDevelopmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Jenny Nelander WahlestedtDevelopmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Agnete KirkebyDevelopmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Shane GrealishDevelopmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Anders BjörklundDevelopmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Malin ParmarDevelopmental and Regenerative Neurobiology, Department of Experimental Medical Science, Lund University, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dopamine (DA) neurons derived from human embryonic stem cells (hESCs) are a promising unlimited source of cells for cell replacement therapy in Parkinson's disease (PD). A number of studies have demonstrated functionality of DA neurons originating from hESCs when grafted to the striatum of rodent and non-human primate models of PD. However, several questions remain in regard to their axonal outgrowth potential and capacity to integrate into host circuitry. Here, ventral midbrain (VM) patterned hESC-derived progenitors were grafted into the midbrain of 6-hydroxydopamine-lesioned rats, and analyzed at 6, 18, and 24 weeks for a time-course evaluation of specificity and extent of graft-derived fiber outgrowth as well as potential for functional recovery. To investigate synaptic integration of the transplanted cells, we used rabies-based monosynaptic tracing to reveal the origin and extent of host presynaptic inputs to grafts at 6 weeks. The results reveal the capacity of grafted neurons to extend axonal projections toward appropriate forebrain target structures progressively over 24 weeks. The timing and extent of graft-derived dopaminergic fibers innervating the dorsolateral striatum matched reduction in amphetamine-induced rotational asymmetry in the animals where recovery could be observed. Monosynaptic tracing demonstrated that grafted cells integrate with host circuitry 6 weeks after transplantation, in a manner that is comparable with endogenous midbrain connectivity. Thus, we demonstrate that VM patterned hESC-derived progenitors grafted to midbrain have the capacity to extensively innervate appropriate forebrain targets, integrate into the host circuitry and that functional recovery can be achieved when grafting fetal or hESC-derived DA neurons to the midbrain.

Indexed as

AmphetamineAnimalsDopaminergic NeuronsDopamine Uptake InhibitorsFemaleHumansHydroxydopaminesMesencephalonMiceNerve FibersNeural PathwaysNeural Stem CellsParkinsonian DisordersProsencephalonRats, NudeStem Cell TransplantationAmphetamineDopamine Uptake InhibitorsHydroxydopaminescell transplantationdopaminergic neuronshuman embryonic stem cellsParkinson's diseaserabies-based tracingRRID: AB_10807945RRID: AB_11034569RRID: AB_1141717RRID: AB_177511RRID: AB_2333092RRID: AB_300798RRID: AB_390204RRID: AB_572263RRID: AB_627128

Identifiers

PMID30007046
PMCPMC6175216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.